Like Pfizer, Roche sees US tax cut boosting 2018 profit
Berlin
ROCHE Holding AG said that US tax cuts for businesses will boost profit this year, offsetting the impact of the company's most significant transformation in decades.
Core earnings per share will grow by a percentage in the high single digits, the Basel, Switzerland-based company said in a statement on Thursday. That compares to a 5 per cent increase last year, when new medicines helped push Roche's profit to 15.34 Swiss francs (S$21.60) a share, less than analysts had estimated. Sales growth will slow this year.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue